Cargando…
Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors
Our team discovered a moderate SphK1 inhibitor, SAMS10 (IC(50) = 9.8 μM), which was screened by computer-assisted screening. In this study, we developed a series of novel diaryl derivatives with improved antiproliferative activities by modifying the structure of the lead compound SAMS10. A total of...
Autores principales: | Geng, Shuangshuang, Chen, Haijiao, Li, Yan, Li, Ying, Pang, Jingxiang, Zhang, Feipeng, Qu, Zhiqiang, Li, Mengjun, Liu, Na, Yao, Qingqiang, Mu, Yanling, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951126/ https://www.ncbi.nlm.nih.gov/pubmed/35335379 http://dx.doi.org/10.3390/molecules27062020 |
Ejemplares similares
-
Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells
por: Hafizi, Redona, et al.
Publicado: (2022) -
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021) -
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis
por: Gu, Minghui, et al.
Publicado: (2022) -
Crosstalk between TLR2 and Sphk1 in microglia in the cerebral ischemia/reperfusion-induced inflammatory response
por: Sun, Wei, et al.
Publicado: (2017)